Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ERCC6 mRNA | affects expression | 21346803
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of ERCC6 mRNA | increases expression | 20064835
|
D004051 |
Diethylhexyl Phthalate |
ERCC6 gene mutant form results in increased susceptibility to Diethylhexyl Phthalate | increases response to substance | 15340056
|
D010126 |
Ozone |
ERCC6 gene mutant form promotes the reaction [Ozone results in increased expression of CXCL2 protein] | increases expression|increases reaction | 17095637
|
D010126 |
Ozone |
ERCC6 gene mutant form promotes the reaction [Ozone results in increased expression of TNF protein] | increases expression|increases reaction | 17095637
|
D010269 |
Paraquat |
ERCC6 gene mutant form results in increased susceptibility to Paraquat | increases response to substance | 15340056 12509265
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of ERCC6 mRNA | decreases expression | 17558810
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ERCC6 mRNA | increases expression | 20106945
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Diethylhexyl Phthalate |
10.06 | 6734493 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
10.06 | 11752688 15322242 14514962 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.04 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.80 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.77 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.14 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.35 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
4.16 | 11874814 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.48 | 15513908 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.21 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.43 | 19183758 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.61 | 15570426 |
MESH:D001176 |
Arthrogryposis |
marker/mechanism |
|
| 18628313 |
MESH:D001249 |
Asthma |
|
Ozone |
2.70 | 16373670 17854713 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.33 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.23 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.93 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.87 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.87 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.90 | 15516495 16777450 18417511 14754758 18315731 19059883 17626835 |
MESH:D002100 |
Cachexia |
|
Ozone |
5.14 | 16183385 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.14 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.14 | 16507464 17306315 15276417 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.82 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.82 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.50 | 18670907 18850075 16120746 |
MESH:D002386 |
Cataract |
marker/mechanism |
|
| 18628313 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.36 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
7.36 | 19524636 20056578 |
OMIM:214150 |
CEREBROOCULOFACIOSKELETAL SYNDROME 1 |
marker/mechanism |
|
| |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.41 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.20 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D003057 |
Cockayne Syndrome |
marker/mechanism |
|
| |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 18628313 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.38 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
Diethylhexyl Phthalate |
4.15 | 16882537 |
MESH:C535992 |
De Sanctis-Cacchione syndrome |
marker/mechanism |
|
| |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
3.92 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.92 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.96 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.65 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.35 | 16714409 15322242 18230668 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.29 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.06 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.81 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.31 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.08 | 16452187 |
MESH:D005911 |
Gliosis |
|
Paraquat |
5.61 | 11124998 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.04 | 10696789 |
MESH:D006130 |
Growth Disorders |
marker/mechanism |
|
| 18628313 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.88 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.88 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.62 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.25 | 15340226 12621046 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.40 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.49 | 16354765 18606429 15340226 8697196 16959395 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.99 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
7.51 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.51 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.98 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.94 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.21 | 16705839 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
15.23 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
15.23 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylhexyl Phthalate |
15.23 | 11940454 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
15.23 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
15.23 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.27 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.27 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
8.11 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
8.11 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Ozone |
4.21 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
marker/mechanism |
|
| |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
5.06 | 18816296 18520028 20464547 20064080 18569708 20135361 20869020 17053015 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
5.06 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
5.06 | 16712894 19931552 17306315 17077188 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
5.06 | 19555203 11884234 |
MESH:D008268 |
Macular Degeneration |
marker/mechanism |
|
| |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.06 | 19082730 16487513 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.55 | 10496685 |
MESH:D008831 |
Microcephaly |
marker/mechanism |
|
| 18628313 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.40 | 16381670 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.24 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.26 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.43 | 11141357 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.43 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.02 | 20056578 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.93 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.54 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.31 | 12854658 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.70 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.50 | 15276417 17306315 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.90 | 11445065 16510128 12911755 11181820 15451049 11124998 15824117 16140633 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.79 | 16190885 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.69 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.49 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Ozone |
12.42 | 18007984 18929643 18381685 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
12.42 | 12504350 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.89 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.59 | 11222880 11896295 11399792 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.13 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.13 | 16039940 |
MESH:D011596 |
Psychomotor Disorders |
marker/mechanism |
|
| 18628313 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
3.00 | 16324872 17997886 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
4.21 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
4.41 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.17 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
4.07 | 16458197 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.71 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
10.07 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
10.07 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
10.07 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.01 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.35 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.84 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.84 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.84 | 16712894 11723127 17306315 16452187 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.71 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
4.03 | 11813266 |
OMIM:600630 |
UV-SENSITIVE SYNDROME |
marker/mechanism |
|
| |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.82 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.04 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.69 | 15886252 |